Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 30, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net income	$ 70,330	$ 33,148
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and write-off of deferred debt issuance costs	38	328
Impairment (gain) of assets	(398)	(1,017)
Depreciation and amortization	7,979	8,889
Deferred taxes, net of valuation allowance	(35,538)
Stock compensation expense	752	643
Board of directors stock compensation	251	219
Changes in operating assets and liabilities:
Accounts receivable	660	4,406
Inventories	(14,964)	11,660
Prepaid expenses and other current assets	(1,889)	(1,901)
Other assets	(46)	34
Accounts payable	2,797	(7,214)
Operating leases, net	(3,268)	(9,781)
Accrued expenses and other liabilities	(2,855)	2,829
Net cash provided by operating activities	23,849	42,243
Cash flows from investing activities:
Additions to property and equipment, net	(4,056)	(1,723)
Net cash used for investing activities	(4,056)	(1,723)
Cash flows from financing activities:
Repurchase of common stock	(12,728)
Proceeds from issuance of common stock from private direct offering, net of offering costs		4,375
Repayment of FILO loan		(15,000)
Proceeds from new FILO loan		17,500
Net repayments under credit facility		(59,733)
Debt issuance costs		(818)
Tax withholdings paid related to net share settlements	(421)
Proceeds from the exercise of stock options	26	4
Net cash used for financing activities	(13,123)	(53,672)
Net increase (decrease) in cash and cash equivalents	6,670	(13,152)
Cash and cash equivalents:
Beginning of period	15,506	18,997
End of period	$ 22,176	$ 5,845